Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Price, Quality and Market Coverage

Marisa Miraldo

No 025cherp, Working Papers from Centre for Health Economics, University of York

Abstract: Within a horizontally differentiation model, we analyse the relative effects of reference pricing and copayment reimbursement on firms pricing and quality strategies as well as on market coverage under different market structures: competitive market, local monopolies and exogenous full market coverage. Results allow us to shed some light on the welfare and total drug expenditure implications of different drug reimbursement policies.

Keywords: Reference Pricing; Co-payment; Product Differentiation (search for similar items in EconPapers)
JEL-codes: D40 I11 O33 (search for similar items in EconPapers)
Pages: 43 pages
Date: 2007-04
New Economics Papers: this item is included in nep-com, nep-hea and nep-mkt
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://www.york.ac.uk/media/che/documents/papers/r ... _market_coverage.pdf First version, 2007 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:chy:respap:25cherp

Access Statistics for this paper

More papers in Working Papers from Centre for Health Economics, University of York Contact information at EDIRC.
Bibliographic data for series maintained by Gill Forder ().